For research use only. Not for therapeutic Use.
Sodium Indanylcarbenicillin(Cat No.:R042148)is a penicillin-class antibiotic designed to combat bacterial infections, especially those caused by Pseudomonas aeruginosa and certain Gram-negative bacteria. This compound is an ester prodrug of carbenicillin, which enhances oral bioavailability and stability in the gastrointestinal tract, allowing for effective systemic absorption. Upon absorption, it hydrolyzes to release carbenicillin, which inhibits bacterial cell wall synthesis, leading to bacterial cell death. Sodium Indanylcarbenicillin is used to treat urinary tract infections and respiratory infections, offering a potent option for specific bacterial management.
Catalog Number | R042148 |
CAS Number | 26605-69-6 |
Synonyms | (2S,5R,6R)-6-[[3-[(2,3-Dihydro-1H-inden-5-yl)oxy]-1,3-dioxo-2-phenylpropyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid Sodium Salt;?(2S,5R,6R)-6-[[3-[(2,3-dihydro-1H-inden-5-yl)oxy]-1,3-dioxo-2-phenylpropyl]amino]-3, |
Molecular Formula | C26H25N2NaO6S |
Purity | ≥95% |
Target | Bacterial |
Storage | Store at -20C |
IUPAC Name | sodium;(2S,5R,6R)-6-[[3-(2,3-dihydro-1H-inden-5-yloxy)-3-oxo-2-phenylpropanoyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate |
InChI | InChI=1S/C26H26N2O6S.Na/c1-26(2)20(24(31)32)28-22(30)19(23(28)35-26)27-21(29)18(15-7-4-3-5-8-15)25(33)34-17-12-11-14-9-6-10-16(14)13-17;/h3-5,7-8,11-13,18-20,23H,6,9-10H2,1-2H3,(H,27,29)(H,31,32);/q;+1/p-1/t18?,19-,20+,23-;/m1./s1 |
InChIKey | QFWPXOXWAUAYAB-XZVIDJSISA-M |
SMILES | CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)OC4=CC5=C(CCC5)C=C4)C(=O)[O-])C.[Na+] |